| Chen, Hao |
NCT04909255: Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive Bladder |
|
|
| Recruiting | 4 | 50 | RoW | mirabegron, Betmiga, oxybutynin, tolterodine, solifenacin, Ditropan, tartrate, vesicare | China Medical University Hospital | Sjogren's Syndrome, Overactive Bladder Syndrome | 08/22 | 08/22 | | |
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 |
|
|
| Recruiting | 4 | 466 | RoW | Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638 | The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd. | Renal Insufficiency, Chronic | 10/25 | 03/26 | | |
NCT04714190: A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression |
|
|
| Recruiting | 3 | 351 | RoW | RC48-ADC, Recombinant Humanized anti-HER2 Monoclonal Antibody-MMAE Conjugate For Injection, Paclitaxel injection, Taxol, Irinotecan Hydrochloride Injection, CAMPTO, Apatinib Mesylate Tablets, Aitan | RemeGen Co., Ltd. | Gastric Cancer, HER2 Overexpressing Gastric Carcinoma | 12/24 | 06/25 | | |
NCT05840341: Clinical Efficacy of QYHJ and Standard Chemotherapy in the Treatment of Advanced Pancreatic Cancer |
|
|
| Recruiting | 3 | 306 | RoW | QingyiHuaji optimized formula, standard chemotherapy | Fudan University | Pancreatic Neoplasms | 12/25 | 12/25 | | |
NCT05180734: PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer |
|
|
| Active, not recruiting | 3 | 878 | RoW | JS001/Placebo, Postoperative Adjuvant Chemotherapy, JS001/placebo combine with Postoperative Adjuvant Chemotherapy | Shanghai Junshi Bioscience Co., Ltd. | Gastric or Esophagogastric Junction Adenocarcinoma | 06/26 | 07/28 | | |
| Active, not recruiting | 2/3 | 580 | RoW | Apatinib 250mg, Camrelizumab, S-1, Oxaliplatin, Apatinib 500mg | Ruijin Hospital | Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma | 12/24 | 08/25 | | |
NCT06206278: Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma |
|
|
| Terminated | 2 | 6 | RoW | Infigratinib, BGJ398, BBP-831 | LianBio LLC | Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 05/24 | 05/24 | | |
NCT06057571: Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor |
|
|
| Recruiting | 2 | 50 | RoW | TT-00420 (tinengotinib) | TransThera Sciences (Nanjing), Inc. | Cholangiocarcinoma Metastatic | 06/25 | 10/25 | | |
NCT04718402: A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Gastric Carcinoma |
|
|
| Terminated | 1 | 21 | RoW | Mitoxantrone Hydrochloride Liposome, intravenous injection | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Advanced Gastric Carcinoma | 05/22 | 05/22 | | |
KYM901, NCT04805307: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 |
|
|
| Recruiting | 1 | 162 | RoW | CMG901 | Keymed Biosciences Co.Ltd | Advanced Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Pancreatic Cancer | 05/24 | 10/24 | | |
NCT05654857: The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu |
|
|
| Recruiting | N/A | 4000 | RoW | PCR test in the stool | Nanjing First Hospital, Nanjing Medical University | Helicobacter Pylori Infection | 08/23 | 08/23 | | |
NCT05533060: Clinical and Molecular Biological Data Collection and Analysis in Patients With TBI |
|
|
| Recruiting | N/A | 200 | RoW | No intervention | Shanghai 6th People's Hospital | Traumatic Brain Injury | 12/27 | 12/27 | | |
NCT05113043: Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults |
|
|
| Recruiting | N/A | 60 | RoW | | Shanghai 6th People's Hospital | Ischemic Stroke, Hemorrhagic Stroke | 12/24 | 12/24 | | |
NCT06241482: Safety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care |
|
|
| Not yet recruiting | N/A | 80 | RoW | Enhanced recovery after surgery, Conventional therapy | Shanghai 6th People's Hospital, Shanghai Jiao Tong University School of Medicine | Neurocritical Care, Traumatic Brain Injury, Cerebrovascular Disease, Moderate or Severe Coma | 04/27 | 04/27 | | |
NCT04524637: The Utility of Thromboelastography in Traumatic Brain Injury |
|
|
| Recruiting | N/A | 500 | RoW | | Shanghai 6th People's Hospital | Traumatic Brain Injury, Coagulation Disorder | 12/24 | 12/24 | | |
NCT04525209: Integrative Proteomic Characterization of Pancreatic Ductal Adenocarcinoma |
|
|
| Not yet recruiting | N/A | 200 | RoW | No intervention | Ruijin Hospital | Tumor Tissues and Non-tumor Tissues From PDAC Patients Were Used for Genomic and Transcriptome Sequencing Analysis and Proteomics and Phosphorylated Proteomics | 12/22 | 12/22 | | |
| Recruiting | N/A | 3000 | RoW | | Peking University First Hospital | Primary Cutaneous Lymphoma | 08/32 | 08/32 | | |
